Science
Why Acquire Shares Of Coherus Oncology Inc (CHRS)?
Coherus Oncology Inc (NASDAQ:CHRS) has a beta value of 0.88 and has seen 1.82 million shares traded in the last trading session. The company, currently
Coherus Oncology Inc (NASDAQ:CHRS) has a beta value of 0.88 and has seen 1.82 million shares traded in the last trading session. The company, currently
© 2024, Powered by Smart TechOne